Cite

    Nauck, M. et al. (n.d.). Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin†. Diabetes, obesity & metabolism. 16 (11), pp. 1111-1120. [Online].